Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives

Archiv der Pharmazie

Volumn 342, Issue 1, 2009, Pages 19-26

  Lin, Kai Wei ^a   Fang, Song Chwan ^b   Hung, Chi Feng ^c   Shieh, Bor Jinn ^d   Yang, Shyh Chyun ^a   Teng, Che Ming ^e   Lin, Chun Nan ^a,f  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f NATIONAL TAITUNG UNIVERSITY   (Taiwan)

Author keywords

Antiplatelet effect; Vasorelaxing activity; Xanthones derivaties

Indexed keywords

3 (4 MORPHOLINOLBUTOXY)XANTHONE; 3 (4 PIPERIDINOBUTOXY)XANTHONE; 3 (4 PYRROLIDINOBUTOXY)XANTHONE; 3 [2 (DIMETHYLAMINO)ETHOXY]XANTHONE; 3 [3 (CYCLOPROPYLAMINO)PROPOXY]XANTHONE; 3 [3 (DIMETHOXY)PROPOXY]XANTHONE; 3 [3 (SEC BUTYLAMINO)PROPOXY]XANTHONE; 3 [4 (4 HYDROXYPIPERIDINO)BUTOXY]XANTHONE; 3 [4 (4 METHYLPIPERAZINO)BUTOXY]XANTHONE; 3 [4 (DIETHYLAMINO)BUTOXY]XANTHONE; 3 [4 (DIMETHYLAMINO)BUTOXY]XANTHONE; 3 [4 (ETHYLAMINO)BUTOXY]XANTHONE; 3 [4 (N BUTYLAMINO)BUTOXY]XANTHONE; 3 [4 (SEC BUTYLAMINO)BUTOXY]XANTHONE; 3 [4 [N METHYL N(2 HYDROXYETHYL)AMINO]BUTOXY]XANTHONE; 3 [5 (DIMETHYLAMINO)PENTOXY]XANTHONE; 3 [6 (DIMETHYLAMINO)HEXOXY]XANTHONE; 3 [[4 (2 HYDROXYETHYL)AMINO]BUTOXY]XANTHONE; [5 (SEC BUTYLAMINO)PENTOXYXANTHONE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; COLLAGEN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; VASODILATATION;

ANIMALS; AORTA; CELLS, CULTURED; FIBRINOLYTIC AGENTS; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RABBITS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; VASODILATION; VASODILATOR AGENTS; XANTHONES;

EID: 58549093200     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800002     Document Type: Article

References (12)

1. C. M. Teng, C. N. Lin, F. N. Ko, K. L. Cheng, T. F. Huang, Biochem. Pharmacol. 1989, 38, 3791-3795.
2. F. N. Ko, C. N. Lin, S. S. Liou, T. F. Huang, C. M. Teng, Eur. J. Pharmacol. 1991, 192, 133-139.
3. I. J. Chen, S. J. Liou, S. S. Liou, C. N. Lin, Gen. Pharmacol. 1993, 24, 1425-1433.
4. C. N. Lin, S. S. Liou, S. C. Lai, H. C. Lin, et al., J. Pharm. Pharmacol. 1995, 47, 588-594.
5. L. W. Wang, J. J. Kang, I. J. Chen, C. M. Teng, C. N. Lin, Bioorg. Med. Chem. 2002, 10, 567-572.
6. M. F. Hsu, C. N. Lin, M. C. Lu, J. P. Wang, Naunyn Schmiede-bergs Arch. Pharmacol. 2004, 369, 507-515.
7. C. N. Lin, S. S. Liou, F. N. Ko, C. M. Teng, J. Pharm. Sci. 1993, 82, 11-16.
8. S. S. Liou, C. M. Teng, F. N. Ko, C. N. Lin, J. Pharm. Sci. 1994, 83, 391-395.
9. D. C. Macmillan, Nature 1966, 211, 140-145.
10. J. R. A. Mitchell, A. A. Sharp, Br. J. Haematol. 1964, 10, 78-93.
11. J. F. Mustard, D. W. Perry, R. L. Kinlough-Rathbone, M. A. Packham, Am.J.Physiol.1975, 228, 1757-1765.
12. C. M. Teng, W. Y. Chen, W. C. Ko, C. H. Ouyang, Biochim. Biophys. Acta 1987, 924, 375 -382.